This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
29 results for: healthcare
post featured image

Off-label use of medication is currently not regulated in Romania. Rather, it is up to the doctors to decide on the off-label use of a...

post featured image

An investigation has been launched by the UK’s Department of Health and Social Care (“DHSC”) with the overall aim of improving healthcare...

post featured image

Momentum and debate about the application of cost-effectiveness analysis to determine the value and prices of prescription drugs in the...

post featured image

Countries and industries have been progressively setting ‘net zero’ targets, adapting legislation and activities to move towards a...

post featured image

In the last week of September 2021, the Polish Cabinet finally published the Plan for Rare Diseases for 2021-2023 (the "Plan"). We...

post featured image

Key Points: 

  • For the privately insured, Medicare, and uninsured populations, the prevalence of the use of preventive care services...
post featured image

On 30 June 2021, a draft bill amending the Act of 12 May 2011 on the Reimbursement of Medicines, Foodstuffs for Special Nutritional...

post featured image

The Australian Federal Government has announced an extension of telehealth funding for general practitioners, allied health providers and...

post featured image

Following the European Commission's (EC) adoption of a proposal for a Regulation on health technology assessment (HTA) in 2018, and the...

post featured image

The Medicines and Medical Devices Act 2021 (the “MMD Act”) was granted royal assent on 11th February 2021. The MMD Act confers broad...

post featured image

The IPHA has updated its self-governance and advertising codes; key updates for those in the pharma sector.

The Irish Pharmaceutical...

post featured image

Earlier this month (March 2021) the Polish Ministry of Health prepared and submitted the Plan for Rare Diseases to the Chancellery of the...

post featured image

The global outlook for M&A in the digital health and particularly the telehealth sector has never been brighter than today.

post featured image

Significant technological and scientific development over the last few years has shown that the EU’s framework on blood, tissues and cells (

post featured image

At a time when the importance of the life sciences industry to our daily lives has never been clearer, the UK Government has been...

post featured image

Portugal published Law no. 4-C/2021, which transposes the Directive (EU) 2020/2020 from the 7th of December 2020, as regards temporary...